Charles River Laboratories International (CRL) Lifted Guidance, Is The Stock Already Pricey?
Charles River Laboratories International (CRL) moved after reporting its strongest organic revenue growth in three years, a Q3 2026 earnings beat, and higher full-year guidance that pointed to firmer demand and wider margins. Despite the earnings beat, Charles River Laboratories International shares fell 7.27% on the day to $326.29 and are down 12.75% over the past week. However, the 90-day share price return of…
The report was published on 06 de novembro de 2026 às 00:50 by Yahoo Finance and is part of the World news coverage.
Quick answers
Who reported this story?
It was first reported by Yahoo Finance on 06 de novembro de 2026 às 00:50.
What is the category?
It is filed under World news on Rio Warzone News.
